TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 14 | 11 | 10 | 17 | -10 | 0 | 8 |
| P | %wins | 100 | 100 | 100 | 100 | 50 | 90 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/11 16:28 | 8/11/11 | ASTM | Aastrom Biosciences Inc | MI | Health | BioPrd | Biological Products, (No Diag | Cresswell Ronald M | MI | D | P | 44 | 2.22 | 1 | 20 | 100 | 40 | D | -39 | 48 | -13 | -19 | -19 | -22 | -15 | 11 | 9 | 6 | 2 | 13 | -26 | ||
3/28/11 10:29 | 3/24/11 | ASTM | Aastrom Biosciences Inc | MI | Health | BioPrd | Biological Products, (No Diag | Cresswell Ronald M | MI | D | P | 44 | 2.19 | 1 | 20 | New | 20 | D | -27 | 28 | 42 | -2 | -13 | -6 | 0 | 0 | 18 | 15 | 18 | 21 | 6 | ||
2/24/04 08:13 | 2/20/04 | CRGN | Curagen Corp | DE | Health | Biolab | Commercial Physical & Biologi | Cresswell Ronald M | CT | D | P | 63 | 6.30 | 0 | 10 | 200 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |